The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
E-Prime® is the leading psychology software tool for designing and conducting experiments with precise stimulus control and timing. With over 100,000 users globally, E-Prime offers drag-and-drop design, advanced data collection, and seamless hardware integration for comprehensive psychological research.
The Department of Psychological and Brain Sciences at Johns Hopkins University integrates research in cognitive psychology, neuroscience, and mental health, with a focus on understanding behavior and brain function.
Griffith University's Psychology, Social Work, and Human Services programs offer comprehensive academic and practical training for careers in mental health, social care, and human services.